The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells From EGFR Inhibition by Erlotinib and Cetuximab

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 (Menadione) Attenuates Hypoxia and MAPK Signaling and Blocks Melanoma Tumorigenesis

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2009English

Inhibition of EGFR Signaling Protects From Mucormycosis

mBio
VirologyMicrobiology
2018English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

P53 and PTEN Expression Contribute to the Inhibition of EGFR Downstream Signaling Pathway by Cetuximab

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Menadione (Vitamin K3) Is a Catabolic Product of Oral Phylloquinone (Vitamin K1) in the Intestine and a Circulating Precursor of Tissue Menaquinone-4 (Vitamin K2) in Rats

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2014English

Suppression of Phosphatase and Tensin Homolog Protects Insulin-Resistant Cells From Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Shikonin Sensitizes Wild‑type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Activation of Akt Protects Cancer Cells From Growth Inhibition Induced by PKM2 Knockdown

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy